Vaccination to keep safe, to win the COVID-19 depends on all! In order to ensure that Qi Jian Biological Products Co., LTD., a manufacturer of COVID-19 vaccines in Changchun, further expands its production scale and improves the production and quality of COVID-19 vaccines. Under the leadership of the company, all departments made emergency dispatch and all workshops worked overtime to accelerate production. The elevator production and goods of the project were completed in only one week, making a contribution to vaccine production and epidemic prevention and control!

Changchun Qi Jian Biological Products Co., Ltd. is a wholly-owned subsidiary of China Biotechnology Co., LTD., a subsidiary of China National Pharmaceutical Group, a state-owned enterprise directly under SASAC. In order to expand the production capacity and packaging capacity of COVID-19 vaccines and meet the current demand for vaccines, Sinopubic China Biologics has adopted the COVID-19 vaccine stock solution produced by Beijing Biologics and expanded the vaccine production capacity by using its six biological products research institutes in Beijing, Wuhan, Changchun, Shanghai, Lanzhou and Chengdu. As of April 12 this year, Changchun Institute of Biological Products has produced 2.89 million doses of COVID-19 vaccine in total. After the completion of the upgrade, Changchun Qijian Biological Products Co., Ltd. is expected to produce 300 million doses of COVID-19 vaccine annually, which will greatly alleviate the global shortage of COVID-19 vaccine.
 
As a key biological products backbone enterprise in Jilin Province, Qi Jian has undertaken many sub-projects of national and provincial scientific research projects, including the national "863" program, the New drug innovation and technology major project, and the provincial science and technology project. It has been rated as "High-tech Enterprise", "Science and Technology Innovation Enterprise of Jilin Province", "5A Honest Enterprise of Jilin Province" and "Famous Enterprise of Jilin Province".
 
Using the technical advantages of cooperation with Siemens, XIDE Elevator has developed and launched the automatic purification, sterilization and epidemic prevention elevator. This epidemic prevention elevator has the function of non-contact call ladder and non-contact floor selection. When no one is in the elevator, the air in the car will be cleansed automatically, which can effectively avoid the spread of virus and cross infection, especially suitable for hospitals, centers for disease control and prevention and other places. This series of elevator products are equipped with contactless IC card layer selection system, intelligent voice layer selection system, face recognition system, mobile APP Bluetooth ladder control system and many other black technologies. In addition, it is equipped with a strong ultraviolet automatic purification and sterilization system, which can automatically kill the bacteria and viruses in the car, so as to meet the standard requirements of epidemic prevention.
 
 
Relying on its own scientific research strength, Jiangsu XIDE Elevator Co., Ltd. has developed intelligent and efficient epidemic prevention elevator, which has built a solid security line for users' healthy travel. Last year, the elevator products we provided for the emergency medical rescue construction project of Changchun Emergency Center and the epidemic Prevention and control headquarters of Huinan County Hospital in Jilin Province have been put into use. This year, we once again provide elevator products and services to Changchun COVID-19 vaccine manufacturers, and we are honored to make a contribution to the country's vaccine production and epidemic prevention and control!